Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia
Clinical trial NCT05001828 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05001828
- Sponsor
- Polaris Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-05
- Primary completion
- 2026-05-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.